Results 171 to 180 of about 2,461,363 (302)

Comparative outcomes of anticoagulant versus antiplatelet therapy in coronary endarterectomy: a meta-analysis. [PDF]

Indian J Thorac Cardiovasc Surg
Comentale G, Ahmadi-Hadad A, Manzo R, Parisi V, Milione A, Damiano A, Calanni Macchio C, Pilato E.   +7 more
europepmc   +1 more source

Antiplatelet Therapy in Elderly.

Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 1998
openaire   +3 more sources

Predicting Device‐Induced Platelet Damage in Assisted Circulation Using a New Biophysical Model and Experimental Validation

Artificial Organs, EarlyView.
Quantitative assessment of a newly proposed CFD‐based biophysical model for predicting device‐induced platelet damage by circulatory assist devices was performed. The new model preserved the relative trends observed previously with the power‐law formulation across a range of clinically relevant pump operating conditions, while demonstrating improved ...
Anik Tarafder, Dong Han, Bartley P. Griffith, Zhongjun J. Wu   +3 more
wiley   +1 more source

Probabilistic Risk-Benefit Profile of Ticagrelor Monotherapy After Short Dual Antiplatelet Therapy: A Bayesian Analysis of the ULTIMATE-DAPT Trial. [PDF]

Clin Pharmacol Ther
Yang N, Xie X, Guo N, Li L, Deng N, Wang X, Yang L, Gao H.   +7 more
europepmc   +1 more source

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

Alimentary Pharmacology &Therapeutics, EarlyView.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala, Sameer Rao, Manas Gunani, Kajol Shah, Anand V. Kulkarni, Karn Wijarnpreecha, Daniel Q. Huang, Pojsakorn Danpanichkul, Ahmed Al‐Khazraji, Kaveh Hajifathalian, Vivek Lingiah, Paul Gaglio, Nikki Duong, Christine Gerula   +13 more
wiley   +1 more source

Add-on antiplatelet therapy in anticoagulated patients with atrial fibrillation. [PDF]

Int J Cardiol Heart Vasc
Matsuoka Y, Minamiguchi H, Sakamoto D, Sunaga A, Okada K, Nakatani D, Kitamura T, Kanda T, Watanabe R, Nagashima K, Higuchi Y, Okumura Y, Sotomi Y, Sakata Y.   +13 more
europepmc   +1 more source

Effect of dual antiplatelet therapy on prognosis of patients with myocardial infarction with nonobstructive coronary artery disease: A meta-analysis. [PDF]

Medicine (Baltimore)
Qin Y, Zhao H, Fu SL, Cheng WL, Zhang J, Zhang YQ, Lian XQ.   +6 more
europepmc   +1 more source

Impact of operative time on complications after PCNL in the elderly (aged ≥70 years): the Safety and Efficacy of Nephrolithotomy in Older patients undergoing PCNL (SENIOR‐PCNL) study

BJU International, EarlyView.
Objectives To evaluate the association between operative time (OT) and postoperative complications after percutaneous nephrolithotomy (PCNL) in elderly patients, and to identify a clinically meaningful OT threshold for risk stratification. Patients and Methods A retrospective international multicentre study was performed including patients aged ≥70 ...
Łukasz Nowak, Wojciech Krajewski, Bhaskar Somani, Tomasz Szydełko, Vineet Gauhar, Steffi Kar Kei Yuen, Matthias Boeykens, Thomas Tailly, Ioannis Mykoniatis, Alba Sierra, Emre T. Sener, Vincent De Coninck, Rifat Burak Ergul, Alberto Olivero, Lazaros Tzelves, Francesco Esperto, Angelis Peteinaris, Yuigi Yuminaga, Qi Hou, Patrick Juliebø‐Jones, Arman Tsaturyan, Bartosz Małkiewicz, Agata Góral, Paulina Biesiadecka, Francisco Javier Lopez Vivo, Mantu Gupta, Juan Serna, Ziv Savin, Anastasios Anastasiadis, Dimitrios Memmos, Charlotte Slots, Rita Pages, Ceyhun Ozdemiroglu, Maria Florencia Frascheri, Rafael Carrasco Moreno, Eugenio Ventimiglia, Panagiotis Kallidonis, Evangelos Liatsikos, Otas Durutovic, Amelia Pietropaolo, Begoña Ballesta Martinez, on behalf of the YAU Working Group Endourology & Urolithiasis and the EAU Endourology Section   +41 more
wiley   +1 more source

Indobufen-based dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and network meta-analysis. [PDF]

J Int Med Res
Gopinath A, Heo J, Fatima A, Yerrajonna A, George H, Mohd R, Turjman T, Azuwike UB, Bien-Aimé DPC, Lefevre JAS, Rech L, Asfaw MD, Ekumbal JR, Dalil L, Khawar MMH.   +14 more
europepmc   +1 more source

Ischaemic stroke and 5‐fluorouracil or capecitabine: A systematic review and meta‐analysis of harms and a retrospective study of the WHO pharmacovigilance database

British Journal of Pharmacology, EarlyView.
Abstract Aim Fluoropyrimidines, including 5‐fluorouracil (5‐FU) and capecitabine, are cornerstone antineoplastic agents for cancer. Case reports suggest that these drugs may be associated with an under‐recognised risk of ischaemic stroke or transient ischaemic attack (TIA).
Sophie Nguyen, Ines Bentahrour, Camille Guerin, Charles Dolladille, Angélique Da Silva, François Cherifi, Elise‐Marie Minoc, Pierre‐Marie Morice, Nicolas Jacquin, Christophe Le Tourneau, Joachim Alexandre, Ahmad Nehme, Etienne Bastien   +12 more
wiley   +1 more source